The global ventral hernia treatment market, valued at USD 4.75 billion in 2022, is projected to grow significantly, reaching an estimated USD 9.4 billion by 2033. This growth corresponds to a compound annual growth rate (CAGR) of 6.4% during the forecast period from 2023 to 2033.
The expansion of the ventral hernia treatment market can be attributed to several key factors, including the increasing incidence of ventral hernias, rising demand for minimally invasive surgical procedures, and a growing geriatric population. Additionally, the availability of technologically advanced products and services is enhancing treatment options and driving market growth.
In the historical period from 2018 to 2022, the market for ventral hernia treatment registered a CAGR of 3.3%, reflecting a steady increase in interest and investment in effective treatment solutions. As healthcare providers continue to prioritize patient outcomes and recovery, the demand for innovative treatment methods is expected to rise.
This upward trajectory highlights substantial opportunities for medical device manufacturers, surgical centers, and healthcare professionals dedicated to improving the management and treatment of ventral hernias, ultimately enhancing the quality of life for patients.
2018 to 2022 Ventral Hernia Treatment Market Demand Analysis vs. Forecast 2023 to 2033
According to market research and competitive intelligence provider Future Market Insights- the market for Ventral hernia treatment reflected a value of 3.3% during the historical period, 2018 to 2022.
The growth was attributed to the increasing prevalence of ventral hernias, the rising demand for minimally invasive surgical procedures, and the availability of advanced hernia repair devices. Moreover, key players have been investing in research and development for innovating novel therapies for ventral hernia treatment. Thus, the market for ventral hernia treatment is expected to register a CAGR of 6.4% in the forecast period 2023 to 2033.
Market Competition
Key players in the ventral hernia treatment market are Medtronic, Becton Dickinson & Company, Braun Melsungen AG, Cook Medical Inc., Cooper Companies Inc., Baxter International, Inc., Integra LifeSciences, W.L. Gore & Associates, AbbVie, Johnson & Johnson Services, Inc.
- Medtronic has developed several mesh products that can be used during hernia repair surgery. These products are designed to provide support to the weakened or damaged tissue in the abdominal wall and help prevent the hernia from recurring.
- Becton Dickinson & Company provides support and education to patients who are undergoing hernia repair surgery. This includes resources and information about the procedure, as well as tips for managing recovery and preventing future hernias.
Key Companies Profiled
- Medtronic
- Becton Dickinson & Company
- Braun Melsungen AG
- Cook Medical Inc.
- Cooper Companies Inc.
- Baxter International, Inc.
- Integra LifeSciences
- W.L. Gore & Associates
- AbbVie
- Johnson & Johnson Services, Inc.
Key Segments Profiled in the Ventral Hernia Treatment Industry Survey
Type:
- Epigastric (stomach area) hernia
- Umbilical (belly button) hernia
- Incisional hernia
Diagnosis:
- Ultrasound
- CT Scan
- MRI
Surgery Type:
- Open hernia surgery
- Laparoscopic surgery
- Robotic hernia surgery
End-use:
- Hospitals
- Ambulatory Surgical Centres
- Clinics
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
